Alan K. Lichtenstein
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Iron Metabolism and Disorders
- Microbiology top 0.2%
- Antimicrobial Peptides and Activities
Papers in
- Hematology 57
- Multiple Myeloma Research and Treatments 55
- Oncology 54
- Cytokine Signaling Pathways and Interactions 11
- Co-authors
- Tomas Ganz (7 shared papers)Robert I. Lehrer (3 shared papers)Joseph Gera (35 shared papers)Yijiang Shi (29 shared papers)Yiping Tu (10 shared papers)Elizabeta Nemeth (3 shared papers)Gary John Schiller (5 shared papers)James R. Berenson (16 shared papers)
- Journals
- Blood (29 papers)Cellular Immunology (10 papers)Journal of Biological Chemistry (10 papers)Oncogene (6 papers)Molecular Cancer Therapeutics (5 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Alan K. Lichtenstein
160 papers receiving 10.3k citations
Alan K. Lichtenstein's Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 3.5k
- Microbiology 1.1k
- Oncology 3.1k
- Genetics 1.1k
- Immunology 1.8k
Countries citing papers authored by Alan K. Lichtenstein
This map shows the geographic impact of Alan K. Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan K. Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan K. Lichtenstein more than expected).
Fields of papers citing papers by Alan K. Lichtenstein
This network shows the impact of papers produced by Alan K. Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan K. Lichtenstein. The network helps show where Alan K. Lichtenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan K. Lichtenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Hit paper breakdown → | 2003 | 1231 |
| 2 | Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells Hit paper breakdown → | 1993 | 881 |
| 3 | Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma Hit paper breakdown → | 1996 | 881 |
| 4 | 1998 | 534 | |
| 5 | 1997 | 319 | |
| 6 | 2004 | 284 | |
| 7 | 1995 | 251 | |
| 8 | 1998 | 225 | |
| 9 | Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779. | 2002 | 205 |
| 10 | BCL-X expression in multiple myeloma: possible indicator of chemoresistance. | 1998 | 204 |
| 11 | The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. | 2000 | 194 |
| 12 | 2001 | 170 | |
| 13 | 2004 | 162 | |
| 14 | Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. | 1985 | 156 |
| 15 | 1990 | 143 | |
| 16 | 1980 | 139 | |
| 17 | 1989 | 139 | |
| 18 | 2005 | 135 | |
| 19 | 2009 | 133 | |
| 20 | 1987 | 129 |
About Alan K. Lichtenstein
Alan K. Lichtenstein is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 162 papers that have together received 10.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (55 papers), PI3K/AKT/mTOR signaling in cancer (27 papers), Immune Cell Function and Interaction (20 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Cytokine Signaling Pathways and Interactions (11 papers), Immune Response and Inflammation (10 papers), Immunotherapy and Immune Responses (10 papers) and Protein Kinase Regulation and GTPase Signaling (9 papers). The work is most often cited by research in Hematology (3.5k citations), Microbiology (1.1k citations), Oncology (3.1k citations), Genetics (1.1k citations) and Immunology (1.8k citations). Alan K. Lichtenstein has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Tomas Ganz, Robert I. Lehrer, Joseph Gera, Yijiang Shi, Yiping Tu, Elizabeta Nemeth, Gary John Schiller, James R. Berenson, Mary Territo and Erika V. Valore. Their work appears in journals such as Blood, Cellular Immunology, Journal of Biological Chemistry, Oncogene and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.